Geron
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Geron and other ETFs, options, and stocks.About GERN
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies.
CEODawn Carter Bir
CEODawn Carter Bir
Employees229
Employees229
HeadquartersFoster City, California
HeadquartersFoster City, California
Founded1990
Founded1990
Employees229
Employees229
GERN Key Statistics
Market cap761.12M
Market cap761.12M
Price-Earnings ratio-5.64
Price-Earnings ratio-5.64
Dividend yield—
Dividend yield—
Average volume12.75M
Average volume12.75M
High today$1.29
High today$1.29
Low today$1.18
Low today$1.18
Open price$1.26
Open price$1.26
Volume5.93M
Volume5.93M
52 Week high$5.34
52 Week high$5.34
52 Week low$1.17
52 Week low$1.17
GERN News
TipRanks 1d
Director’s Bold Move: A Major Investment in Geron!New insider activity at Geron ( (GERN) ) has taken place on May 14, 2025. Protect Your Portfolio Against Market Uncertainty Director Bryan Lawlis has made a s...
Simply Wall St 5d
Analysts Have Lowered Expectations For Geron Corporation After Its Latest ResultsThere's been a notable change in appetite for Geron Corporation ( ) shares in the week since its quarterly report, with the stock down 14% to US$1.18. It looks...
Seeking Alpha 6d
Geron slips as Scotiabank downgrades on sales challenges for blood cancer drugShares of Geron (NASDAQ:GERN) traded lower for the third straight session on Thursday as Scotiabank downgraded the U.S. biotech, citing potential challenges to...
Analyst ratings
67%
of 9 ratingsBuy
66.7%
Hold
33.3%
Sell
0%
People also own
Based on the portfolios of people who own GERN. This list is generated using Robinhood data, and it’s not a recommendation.